India leads the world in the export of generic medications (>20%), with a value of approximately US$ 14 billion and an annual growth rate of 30%. India is currently exporting pharmaceuticals to over 200 countries, with the US being one of the largest markets for these products.
The pharmaceutical industry in India is the third largest in the world by volume and the 13th largest by value as of 2023. More than 60,000 generic medications are produced by the industry across 60 distinct therapeutic categories. In the fiscal year 2022–2023, pharmaceutical exports brought in $25.3 billion for India.
List of Top 9 Pharmaceuticals & Drugs in India (BSE) based on Net Profit.
| Company Name | Net Profit (Rs. cr) |
| Dr Reddys Labs | 2,612.80 |
| Cipla | 2,469.53 |
| Divis Labs | 1,808.15 |
| Sun Pharma | 1,690.72 |
| Zydus Life | 1,529.20 |
| Mankind Pharma | 1,248.26 |
| Aurobindo Pharm | 1,230.41 |
| Glenmark | 1,208.77 |
| Alkem Lab | 1,134.47 |
Source: BSE, India, last updated 23 February, 2024
This news is a creative derivative product from articles published in famous peer-reviewed journals and Govt reports:
Reference:
1. Luo, Z., Callaert, J., Zeng, D., & Looy, B. V. (2024). Knowledge recombination, environmental turbulence and firms’ innovation quality: the evidence from Chinese pharmaceutical industry. European Journal of Innovation Management, 27(1), 69-95.
2. Alzghoul, A., Aboalganam, K. M., & Al-Kasasbeh, O. (2024). Nexus among green marketing practice, leadership commitment, environmental consciousness, and environmental performance in Jordanian pharmaceutical sector. Cogent Business & Management, 11(1), 2292308.
3. Suhandi, V., & Chen, P. S. (2023). Closed-loop supply chain inventory model in the pharmaceutical industry toward a circular economy. Journal of Cleaner Production, 383, 135474.
4. Rault-Chodankar, Y. M., & Kale, D. (2023). ‘Manufacturers without factories’ and economic development in the Global South: India’s pharmaceutical firms. Journal of Economic Geography, 23(2), 319-341.
5. Gupta, J., Rathore, P., & Kashiramka, S. (2023). Impact of intellectual capital on the financial performance of innovation-driven pharmaceutical firms: Empirical evidence from India. Journal of the Knowledge Economy, 14(2), 1052-1076.
Disclaimer: This news is for information and research purposes only. It is not intended for financial advice.
Declaration of competing interest: Publisher and owner of this web-portal hereby declare that there is no competing interest.
